PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Vascular BioSciences, Inc

Press Release


Receive press releases from Vascular BioSciences, Inc: By Email RSS Feeds:

Vascular BioSciences Congratulates VP of Communications, Dr Susana Peinado, Ph.D., on Being Awarded Her Doctorate from UCSB School of Communication


Newly awarded PhD, Dr. Susana Peinado, lauded for her achievements.

Goleta, CA, June 05, 2016 --(PR.com)-- Vascular BioSciences announced today that Dr. Susana Peinado, Ph.D., Vice President of Communications at Vascular BioSciences, was awarded a doctoral degree from the UCSB School of Communication.

In addition to her outstanding work at Vascular Biosciences, Dr. Peinado has received numerous awards for her accomplishments, including a Dean’s Advancement Fellowship, a Health Communication Doctoral Fellowship at the Cancer Communication Research Center, National Cancer Institute, a Graduate Opportunity Fellowship, and a SAGE Sara Miller McCune Fellowship.

Dr. Peinado’s dissertation research, “The Use of Emotional Shifts in Health Messages as a Strategy for Generating Talk and Promoting Attitude, Belief, and Behavior Change,” focused on how conversation following exposure to health messages influences attitudes and behavior.

“We are extremely proud of Dr. Peinado and all of her achievements,” said David Mann, CEO and Chairman of Vascular BioSciences and VBS Pharmaceuticals. “Dr. Peinado’s accomplishment is a testament to her hard work and dedication to the field of health communication, and we are proud to have her as part of our team here at Vascular BioSciences.”

About Vascular BioSciences

Vascular BioSciences, a diversified biomedical company with operations in California and North Carolina, provides targeted solutions for serious diseases in order to enhance and prolong human life.

Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides molecular diagnostic services, and through its majority owned subsidiary VBS Pharmaceuticals, develops targeted therapeutics for patients with difficult-to-treat diseases.

For more information about VBS is available at www.vascularbiosciences.com.

For more information, please contact dmann@vascularbiosciences.com.
Contact Information
Vascular BioSciences, Inc
David Mann
919-313-4826
Contact
www.vascularbiosciences.com

Click here to view the list of recent Press Releases from Vascular BioSciences, Inc
Promote Your Business